Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ProCell Surgical is a medical technology company focused on improving patient outcomes through advanced intraoperative blood salvage solutions. The company's flagship product, the ProCell Autologous Cell Salvage System, is designed to recover high-quality red blood cells from surgical sponges that would otherwise be discarded. By utilizing a proprietary sponge-shaking extraction process, the system maximizes the volume of salvaged blood available for reinfusion, thereby reducing the need for allogeneic blood transfusions. This technology is particularly relevant in complex surgical procedures where significant blood loss is anticipated, such as cardiac, orthopedic, and trauma surgeries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ProCell Surgical.